What is the workup for hypercalcemia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 9, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Workup for Hypercalcemia

The diagnostic evaluation for hypercalcemia should include measuring serum concentrations of intact parathyroid hormone (iPTH), parathyroid hormone-related protein (PTHrP), 1,25-dihydroxyvitamin D, 25-hydroxyvitamin D, calcium, albumin, magnesium, and phosphorus. 1

Initial Assessment

Step 1: Confirm Hypercalcemia

  • Measure total serum calcium and albumin to calculate corrected calcium
  • Ideally, measure ionized calcium (more accurate than total calcium) 2
  • Hypercalcemia is defined as:
    • Mild: Total calcium <12 mg/dL (<3 mmol/L)
    • Moderate: Total calcium 12-14 mg/dL (3-3.5 mmol/L)
    • Severe: Total calcium ≥14 mg/dL (≥3.5 mmol/L) 3

Step 2: Assess for Symptoms and Severity

  • Mild hypercalcemia: Often asymptomatic or with constitutional symptoms like fatigue and constipation
  • Severe hypercalcemia: Nausea, vomiting, dehydration, confusion, somnolence, polyuria, polydipsia, abdominal pain, myalgia 1, 3

Diagnostic Algorithm

Step 3: Measure Intact PTH

This is the most critical initial test to distinguish between PTH-dependent and PTH-independent causes:

  • Elevated/normal PTH: Consistent with primary hyperparathyroidism
  • Suppressed PTH (<20 pg/mL): Indicates non-PTH mediated cause (e.g., malignancy) 3

Step 4: Additional Laboratory Tests Based on PTH Results

If PTH is Elevated or Normal:

  • 24-hour urinary calcium excretion and creatinine clearance
    • Low urinary calcium (<100 mg/24h): Consider familial hypocalciuric hypercalcemia
    • High urinary calcium (>300 mg/24h): Typical of primary hyperparathyroidism
  • Serum creatinine to assess kidney function
  • 25-hydroxyvitamin D to rule out vitamin D deficiency
  • Assess for medications that may cause hypercalcemia (thiazides, lithium, calcium supplements)

If PTH is Suppressed:

  • PTHrP measurement (elevated in humoral hypercalcemia of malignancy)
  • 1,25-dihydroxyvitamin D (elevated in granulomatous diseases, lymphomas)
  • 25-hydroxyvitamin D (elevated in vitamin D intoxication)
  • Serum and urine protein electrophoresis (to detect multiple myeloma)
  • Complete blood count with differential
  • Thyroid function tests (hyperthyroidism can cause hypercalcemia)
  • Consider chest X-ray or CT scan to evaluate for malignancy or granulomatous disease 1

Common Etiologies to Consider

  1. Primary Hyperparathyroidism (PHPT): Most common cause of outpatient hypercalcemia (~90% of cases along with malignancy) 3

    • Characterized by elevated or inappropriately normal PTH
    • Often discovered incidentally on routine blood tests
  2. Malignancy-Associated Hypercalcemia: Most common cause of inpatient hypercalcemia 4

    • Mechanisms include:
      • PTHrP production (suppressed iPTH, low/normal calcitriol)
      • Increased calcitriol production
      • Localized osteolytic hypercalcemia
    • Most common in squamous cell lung cancer 1
  3. Other Causes:

    • Granulomatous diseases (sarcoidosis, tuberculosis)
    • Medications (thiazides, lithium, vitamin A or D supplements)
    • Endocrine disorders (thyrotoxicosis, adrenal insufficiency)
    • Chronic kidney disease with tertiary hyperparathyroidism 2

Special Considerations

Chronic Kidney Disease

  • In CKD patients, maintain corrected total calcium within the normal range (8.4-9.5 mg/dL) 1
  • If calcium exceeds 10.2 mg/dL in CKD patients:
    • Reduce or discontinue calcium-based phosphate binders
    • Reduce or discontinue vitamin D sterols
    • Consider low calcium dialysate if hypercalcemia persists 1

Pitfalls to Avoid

  • Relying solely on total calcium without correcting for albumin
  • Failing to measure PTH as the initial diagnostic test
  • Not considering medication-induced causes
  • Overlooking familial hypocalciuric hypercalcemia (which typically doesn't require treatment)
  • Delaying treatment for severe symptomatic hypercalcemia while completing diagnostic workup 3, 5

Treatment Considerations

While not the focus of the diagnostic workup, it's worth noting that treatment depends on severity:

  • Mild asymptomatic hypercalcemia: May not need acute intervention
  • Symptomatic or severe hypercalcemia: Requires hydration and IV bisphosphonates
  • For hypercalcemia of malignancy: Treat underlying cancer
  • For PHPT: Consider parathyroidectomy based on age, calcium level, and end-organ involvement 3

Remember that identifying and treating the underlying cause is essential for long-term management of hypercalcemia.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Investigation of hypercalcemia.

Clinical biochemistry, 2012

Research

Hypercalcemia: A Review.

JAMA, 2022

Research

Evaluation and therapy of hypercalcemia.

Missouri medicine, 2011

Research

Hypercalcemic crisis.

The Medical clinics of North America, 1995

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.